| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/17476348.2014.860357 |
| P698 | PubMed publication ID | 24378218 |
| P2093 | author name string | Walter T McNicholas | |
| Sophie J Crinion | |||
| P2860 | cites work | Respiration during sleep in normal man | Q24563458 |
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study | Q30474724 | ||
| Impact of sleep in COPD. | Q33836957 | ||
| Adipokines: inflammation and the pleiotropic role of white adipose tissue | Q34356530 | ||
| Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate | Q34718697 | ||
| Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long-term follow up and effect on survival | Q35532492 | ||
| Effect of non-invasive mechanical ventilation on sleep and nocturnal ventilation in patients with chronic respiratory failure | Q35533743 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| Cognitive behavioral therapy for insomnia comorbid with COPD is feasible with preliminary evidence of positive sleep and fatigue effects | Q35596667 | ||
| Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes | Q35911595 | ||
| Cognitive benefits of sleep and their loss due to sleep deprivation | Q36095567 | ||
| Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease | Q36159992 | ||
| Systemic effects of smoking | Q36818050 | ||
| Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea | Q36920927 | ||
| Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). | Q36945365 | ||
| Hypnotic use for insomnia management in chronic obstructive pulmonary disease | Q37240680 | ||
| Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea | Q37638714 | ||
| Obstructive sleep apnea in chronic obstructive pulmonary disease patients | Q37822262 | ||
| Night-time symptoms: a forgotten dimension of COPD. | Q37924454 | ||
| Supplemental oxygen needs during sleep. Who benefits? | Q38070140 | ||
| Phosphodiesterase-4 inhibitor therapy for lung diseases | Q38105165 | ||
| Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases | Q39311282 | ||
| There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study | Q39713170 | ||
| C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease | Q40277494 | ||
| Pathophysiology of obstructive sleep apnoea | Q40432646 | ||
| Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks | Q41226204 | ||
| Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial | Q41293592 | ||
| Myocardial stress. Exercise versus sleep in patients with COPD. | Q41576053 | ||
| Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome | Q43105664 | ||
| Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease | Q43291142 | ||
| Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. | Q43588726 | ||
| Influence of noninvasive positive pressure ventilation on inspiratory muscles. | Q43690446 | ||
| Perception of fatigue and quality of life in patients with COPD. | Q43743337 | ||
| Pulmonary rehabilitation improves sleep quality in chronic lung disease. | Q44229885 | ||
| The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients | Q44648490 | ||
| Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease | Q44667729 | ||
| Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. | Q44854580 | ||
| Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. | Q44952643 | ||
| Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome | Q45894281 | ||
| The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease | Q46515732 | ||
| High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey | Q46745909 | ||
| Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study | Q46960378 | ||
| Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey | Q47787776 | ||
| Sleep quality in chronic obstructive pulmonary disease | Q48235225 | ||
| Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease | Q48245892 | ||
| Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease | Q48393784 | ||
| Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial | Q48409630 | ||
| Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. | Q48418702 | ||
| Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep | Q48438342 | ||
| Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety. | Q48522834 | ||
| Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome | Q48528105 | ||
| Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease | Q48549525 | ||
| Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure | Q48634373 | ||
| Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease | Q48641123 | ||
| Elevated C-reactive protein in patients with obstructive sleep apnea | Q48660954 | ||
| Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. | Q48763319 | ||
| Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. | Q48764914 | ||
| Breathing during sleep in patients with nocturnal desaturation. | Q48775677 | ||
| Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. | Q48809399 | ||
| Association of chronic obstructive pulmonary disease and sleep apnea syndrome. | Q48827347 | ||
| The relation of sleep complaints to respiratory symptoms in a general population. | Q48853214 | ||
| Theophylline in obstructive sleep apnea. A double-blind evaluation | Q48888095 | ||
| Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. | Q48888102 | ||
| Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. | Q48943620 | ||
| Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. | Q49084641 | ||
| One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life. | Q51893769 | ||
| Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey | Q57786024 | ||
| P433 | issue | 1 | |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 79-88 | |
| P577 | publication date | 2013-12-30 | |
| P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
| P1476 | title | Sleep-related disorders in chronic obstructive pulmonary disease | |
| P478 | volume | 8 |
| Q36540077 | Clinical update sleep: year in review 2015-2016. |
| Q37198415 | Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory. |
| Q47994067 | Impact of sleep quality on functional capacity, peripheral muscle strength and quality of life in patients with chronic obstructive pulmonary disease |
| Q36283226 | Lung Disease and Hypertension |
| Q41887098 | Non-invasive ventilation with intelligent volume-assured pressure support versus pressure-controlled ventilation: effects on the respiratory event rate and sleep quality in COPD with chronic hypercapnia. |
| Q93332082 | Validity and Reliability of the Major Depression Inventory for Persons With Dual Sensory Loss |
Search more.